INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 98 filers reported holding INSYS THERAPEUTICS INC NEW in Q1 2019. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,000 | -50.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $2,000 | +100.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $1,000 | -50.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $2,000 | -33.3% | 200 | 0.0% | 0.00% | -50.0% |
| Q2 2017 | $3,000 | +50.0% | 200 | 0.0% | 0.00% | +100.0% |
| Q1 2017 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $2,000 | -33.3% | 200 | 0.0% | 0.00% | -50.0% |
| Q2 2016 | $3,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $3,000 | -50.0% | 200 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $6,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $6,000 | -14.3% | 200 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $7,000 | +16.7% | 200 | +100.0% | 0.00% | 0.0% |
| Q1 2015 | $6,000 | -33.3% | 100 | -66.7% | 0.00% | -60.0% |
| Q2 2014 | $9,000 | – | 300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 8,912,072 | $142,504,000 | 2.66% |
| Antipodean Advisors LLC | 342,294 | $5,473,000 | 2.48% |
| JW Asset Management, LLC | 221,538 | $3,542,000 | 2.31% |
| Parametrica Management Ltd | 33,562 | $537,000 | 1.92% |
| 12 West Capital Management LP | 623,791 | $9,974,000 | 1.39% |
| Folger Hill Asset Management LP | 1,418,138 | $22,676,000 | 1.27% |
| Bellevue Group AG | 281,000 | $4,493,000 | 0.82% |
| Plymouth Lane Capital Management, LLC | 55,300 | $884,000 | 0.78% |
| Orbimed Advisors | 4,557,740 | $72,878,000 | 0.77% |
| DIALECTIC CAPITAL MANAGEMENT, LP | 79,550 | $1,272,000 | 0.60% |